The In Vitro Fertilization Test market research report covers a worldwide outlook of the industry with specifically studying the manufacturers/ key market players. The historical, current, and forecast sales data provided in the report highlights the market's latest trends and future growth scope. The upcoming trends and anticipated risk factors of the market are also covered in the report giving the holistic prospective of the market. The segmentation by type and application is studied at the country level for the study period 2022 to 2028.
As the global economy mends, the 2021 growth of In Vitro Fertilization Test will have significant change from previous year. According to this latest study, the global In Vitro Fertilization Test market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global In Vitro Fertilization Test market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States In Vitro Fertilization Test market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global In Vitro Fertilization Test market, reaching US$ million by the year 2028. As for the Europe In Vitro Fertilization Test landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main In Vitro Fertilization Test players cover CooperSurgical, Inc., Vitrolife AB, Igenomix, and Natera, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of In Vitro Fertilization Test market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
- Embryo Biopsy
- Preimplantation Genetic Testing for Aneuploidy
- KIR-HLAC Genotyping
- Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
- Hospital
- IVF Research Center
- Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
- CooperSurgical, Inc.
- Vitrolife AB
- Igenomix
- Natera
- iGLS
- CiceroDx
- Esco Micro Pte Ltd.
- Texas Fertility Center